Literature DB >> 7644963

Surgical results of lumbar spinal stenosis. A comparison of patients with or without previous back surgery.

A Herno1, O Airaksinen, T Saari, T Sihvonen.   

Abstract

STUDY
DESIGN: This retrospective study was designed to investigate the effects of previous back surgery in patients undergoing surgical procedure for lumbar spinal stenosis.
OBJECTIVES: The authors evaluated the results of singly operated and repeat surgery patients operated on for lumbar spinal stenosis, and compared prognostic factors correlated with the results for these two groups. SUMMARY OF BACKGROUND DATA: Repeat back surgery is generally not as successful as a first operation, but few studies evaluate the effects of previous back surgery on the surgical outcome of patients with lumbar spinal stenosis.
METHODS: The subjective disability of singly operated and repeat surgery patients as assessed by the Oswestry questionnaire was compared with clinical data and myelographic findings to identify factors predictive of outcome.
RESULTS: The mean Oswestry score was 31.0 for singly operated patients and 40.9 for repeat surgery patients (P = 0.0001). The outcome was excellent-to-good in 67% of singly operated patients and in 46% of repeat surgery ones (P < 0.0017). Severe myelographic findings correlated significantly with good outcome in the singly operated group but not in the repeat surgery group. Coexisting disease contributed significantly to poor outcome in the repeat surgery group, but not in the singly operated group. The optimum time interval for achieving successful results from subsequent surgery is at least 18 months after previous surgery. In the regression analysis, the prognostic preoperative variables for good outcome was block stenosis on myelography in the singly operated patients and age over 50 years and no coexisting disease in the repeat surgery patients.
CONCLUSIONS: Previous back surgery had a highly significant worsening effect on the outcome of patients reoperated on for lumbar spinal stenosis. Not even a very well-established diagnosis of lumbar spinal stenosis, as confirmed by myelography and during surgery, could guarantee as successful a surgical outcome in the repeat surgery patients as that in the singly operated patients.

Entities:  

Mesh:

Year:  1995        PMID: 7644963     DOI: 10.1097/00007632-199504150-00015

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  Bone Morphogenetic Protein in Anterior Lumbar Interbody Fusions: A Propensity-Matched Medicare Outcome Analysis.

Authors:  Syed I Khalid; Ravi S Nunna; Rachyl M Shanker; Kyle B Thomson; Rown Parola; Owoicho Adogwa; Ankit I Mehta
Journal:  Int J Spine Surg       Date:  2022-06-14

2.  Clinical outcomes and safety assessment in elderly patients undergoing decompressive laminectomy for lumbar spinal stenosis: a prospective study.

Authors:  Asgeir S Jakola; Andreas Sørlie; Sasha Gulati; Oystein P Nygaard; Stian Lydersen; Tore Solberg
Journal:  BMC Surg       Date:  2010-11-22       Impact factor: 2.102

3.  Influence of previous surgery on patient-rated outcome after surgery for degenerative disorders of the lumbar spine.

Authors:  Pascal Zehnder; Emin Aghayev; Tamas F Fekete; Daniel Haschtmann; Tim Pigott; Anne F Mannion
Journal:  Eur Spine J       Date:  2016-01-22       Impact factor: 3.134

4.  Obese people benefit from lumbar spinal stenosis surgery as much as people of normal weight.

Authors:  Henni Myllykangas; Leena Ristolainen; Heikki Hurri; Jouni Lohikoski; Hannu Kautiainen; Ville Puisto; Heikki Österman; Mikko Manninen
Journal:  J Orthop Surg Res       Date:  2021-09-07       Impact factor: 2.359

5.  The factors of deterioration in long-term clinical course of lumbar spinal canal stenosis after successful conservative treatment.

Authors:  Masanori Tsubosaka; Shuichi Kaneyama; Tomonori Yano; Koichi Kasahara; Aritetsu Kanemura; Masato Takabatake; Hiroaki Hirata; Masatoshi Sumi
Journal:  J Orthop Surg Res       Date:  2018-09-18       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.